Darwin EU study: Overall survival in patients with non-small cell lung cancer treated with selected immunotherapies
Darwin EU study: Is there a link between blood clots and common painkillers in women who use hormonal birth control
Darwin EU: How often respiratory syncytial virus (RSV) affects different age groups in Europe
Darwin EU study: Use of higher-risk antibiotics from the WHO Watch list, including azithromycin
Darwin EU study: Background incidence rates of selected vaccine adverse events of special in Europe
Minutes of the CAT meeting 21-23 January 2026
Annual report on the use of the special contribution for orphan medicinal products - 2025
Questions and answers on the use of out-of-specification batches of authorised cell and tissue-based advanced therapy medicinal products
Consolidated 3-year work plan for the clinical domain
Scientific advice and protocol assistance adopted during the CHMP meeting 23-26 February 2026